• Title/Summary/Keyword: Respiratory infections

Search Result 582, Processing Time 0.029 seconds

Impact of antimicrobial resistance in the $21^{st}$ century

  • Song, Jae-Hoon
    • Proceedings of the Korean Society for Applied Microbiology Conference
    • /
    • 2000.04a
    • /
    • pp.3-6
    • /
    • 2000
  • Antimicrobial resistance has been a well-recognized problem ever since the introduction of penicillin into clinical use. History of antimicrobial development can be categorized based on the major antibiotics that had been developed against emerging resistant $pathogens^1$. In the first period from 1940 to 1960, penicillin was a dominating antibiotic called as a "magic bullet", although S.aureus armed with penicillinase led antimicrobial era to the second period in 1960s and 1970s. The second stage was characterized by broad-spectrum penicillins and early generation cephalosporins. During this period, nosocomial infections due to gram-negative bacilli became more prevalent, while those caused by S.aureus declined. A variety of new antimicrobial agents with distinct mechanism of action including new generation cephalosporins, monobactams, carbapenems, ${\beta}$-lactamase inhibitors, and quinolones characterized the third period from 1980s to 1990s. However, extensive use of wide variety of antibiotics in the community and hospitals has fueled the crisis in emerging antimicrobial resistance. Newly appeared drug-resistant Streptococcus pneumoniae (DRSP), vancomycin-resistant enterococci (VRE), extended-spectrum ${\beta}$-lactamase-producing Klebsiella, and VRSA have posed a serious threat in many parts of the world. Given the recent epidemiology of antimicrobial resistance and its clinical impact, there is no greater challenge related to emerging infections than the emergence of antibiotic resistance. Problems of antimicrobial resistance can be amplified by the fact that resistant clones or genes can spread within or between the species as well as to geographically distant areas which leads to a global concern$^2$. Antimicrobial resistance is primarily generated and promoted by increased use of antimicrobial agents. Unfortunately, as many as 50 % of prescriptions for antibiotics are reported to be inappropriate$^3$. Injudicious use of antibiotics even for viral upper respiratory infections is a universal phenomenon in every part of the world. The use of large quantities of antibiotics in the animal health industry and farming is another major factor contributing to selection of antibiotic resistance. In addition to these background factors, the tremendous increase in the immunocompromised hosts, popular use of invasive medical interventions, and increase in travel and mixing of human populations are contributing to the resurgence and spread of antimicrobial resistance$^4$. Antimicrobial resistance has critical impact on modem medicine both in clinical and economic aspect. Patients with previously treatable infections may have fatal outcome due to therapeutic failure that is unusual event no more. The potential economic impact of antimicrobial resistance is actually uncountable. With the increase in the problems of resistant organisms in the 21st century, however, additional health care costs for this problem must be enormously increasing.

  • PDF

Mucopolysaccharidosis Type III: review and recent therapies under investigation

  • Lee, Jun Hwa
    • Journal of Interdisciplinary Genomics
    • /
    • v.2 no.2
    • /
    • pp.20-25
    • /
    • 2020
  • Mucopolysaccharidosis type III (MPS III or Sanfilippo syndrome) is a multisystem lysosomal storage disease that is inherited in an autosomal recessive manner. It consists of four subtypes (MPS IIIA, B, C, and D), each characterized by the deficiency of different enzymes that catalyze the metabolism of the glycosaminoglycan heparan sulfate at the lysosomal level. The typical clinical manifestation of MPS III includes progressive central nervous system (CNS) degeneration with accompanying systemic manifestations. Disease onset is typically before the age of ten years and death usually occurs in the second or third decade due to neurological regression or respiratory tract infections. However, there is currently no treatment for CNS symptoms in patients with MPS III. Invasive and non-invasive techniques that allow drugs to pass through the blood brain barrier and reach the CNS are being tested and have proven effective. In addition, the application of genistein treatment as a substrate reduction therapy is in progress.

Left Bronchoesophageal Fistula Misdiagnosed as Chronic Empyema Thoracis (만성 농흉으로 오진되었던 좌측 주기관지식도루 - 치험 1례 -)

  • 이두연;조현민;정은규;함석진;김상진;이응석
    • Journal of Chest Surgery
    • /
    • v.35 no.1
    • /
    • pp.68-72
    • /
    • 2002
  • Congenital bronchoesophageal fistula is a rare anomaly that may cause fatal complications if it goes unnoticed for many years. This anomaly may have various symptoms such as respiratory infections, coughing bouts when eating or drinking and even hemoptysis. Surgical resection is the treatment of choice and is definitive in almost cases. We report a case of type I congenital bronchoesophageal fistula misdiagnosed as chronic empyema thoracis with literature review.

Collective Review of Pulmonary Hamartoma in Korea (폐과오종 [Collective Review])

  • Jo, Gyu-Seok;Park, Ju-Cheol;Yu, Se-Yeong
    • Journal of Chest Surgery
    • /
    • v.18 no.3
    • /
    • pp.470-473
    • /
    • 1985
  • We performed clinical analysis about 20 cases of pulmonary parenchymal and intrabronchial hamartoma in Korea by literatures of the Korean Journal of Thoracic and Cardiovascular Surgical Society during 8 years from September 1976 to September 1984 and in addition to our hospital experienced 4 cases of pulmonary parenchymal hamartoma during same periods. 1] There were no cases below second decades. 2] Patients of pulmonary parenchymal hamartoma were asymptomatic, but patients of intrabronchial hamartoma were symptomatic [dyspnea & frequent upper respiratory tract infections]. 3] Pulmonary parenchymal hamartoma were confirmed by removal of mass, but intrabronchial hamartoma were confirmed by bronchoscopic biopsy. 4] There were no malignant changes in both type of pulmonary hamartoma.

  • PDF

Surgical Treatment of the Morgagni Hernia: report of one case (Morgagni 탈장증 수술 1예)

  • 김송명
    • Journal of Chest Surgery
    • /
    • v.12 no.4
    • /
    • pp.429-433
    • /
    • 1979
  • Morgagni hernia is a rare condition of the congenital diaphragmatic hernia which Is located at the anteromedial portion of the diaphragm, and is located immediately posterior to the sternum. Its cause is considered by embryologic defect and the abdominal organs are passed through a defect. The incidence is predirected women over 50 years old. Its synonym is hernia of subcostosternal, retrosternal, parasternal, rectocostoxiphoid, anterior diaphragmatic or Larrey`s. This report presents a symptomatic Morgagni hernia of ten months old male child on whom the diagnosis was established and was operated at the Busan Gospel Hospital. This patient was admitted with the chief complaints of mild cyanosis, frequent upper respiratory infections and protrusion of the right lower anterior chest. Herniorrhaphy was performed through the upper abdominal midline incision, hernial contents of the omentum and the colon, and sac as noticed from the Larrey`s space measuring 4 x 2 cm. in diameter and oval in shape. Interrupted sutures without difficulty repaired the defect. The cyanosis was disappeared and the patient had uneventful course of post-operative period. The patient was discharged at 7th. postoperative day. This case presentation with a brief review of literatures is given.

  • PDF

Nephrotic syndrome: what's new, what's hot?

  • Kang, Hee Gyung;Cheong, Hae Il
    • Clinical and Experimental Pediatrics
    • /
    • v.58 no.8
    • /
    • pp.275-282
    • /
    • 2015
  • While the incidence of nephrotic syndrome (NS) is decreasing in Korea, the morbidity of difficult-to-treat NS is significant. Efforts to minimize treatment toxicity showed that prolonged treatment after an initial treatment for 2-3 months with glucocorticosteroids was not effective in reducing frequent relapses. For steroid-dependent NS, rituximab, a monoclonal antibody against the CD20 antigen on B cells, was proven to be as effective, and short-term daily low-dose steroids during upper respiratory infections reduced relapses. Steroid resistance or congenital NS are indications for genetic study and renal biopsy, since the list of genes involved in NS is lengthening.

Proteomic analysis of proteins Secreted by Human Bronchial Epithelial Cells in Response to Pathogenic Bacterial Infections

  • Oh, Mi-Jung;Park, Mi-Ja;Lee, Ji-Yeon;Park, Ji-Woo;Lee, Na-Gyong;Jung, Sung-Yun;Kim, Dae-Kyong
    • Proceedings of the PSK Conference
    • /
    • 2003.04a
    • /
    • pp.220-221
    • /
    • 2003
  • Bacterial infection is a very complex process in which both pathogens and host cells play crucial roles, and the host cells undergo drastic changes in their physiology, releasing various proteins in response to the pathogenic infection. Human airway epithelial surface serves as a first line of defense against microorganisms and the external environment. It is well known that bronchial epithelial cells secrete various chemokines and cytokines such as IL-6 and IL-8 to cope with various respiratory pathogens. (omitted)

  • PDF

Investigation on the technology trend in Platycodon grandiflorum by the patent analysis

  • Kim, Chang-Kug
    • Proceedings of the Plant Resources Society of Korea Conference
    • /
    • 2018.10a
    • /
    • pp.46-46
    • /
    • 2018
  • The Platycodon grandiflorum (balloon flower) has been used as food material and traditional medicine in Asia. The roots have been used in traditional medicine to treat coughs, upper respiratory infections, and sore throats. Using 1,603 valid patents from 6 countries, we analyzed the patent trend based on year, countries, applicants, and technology. The technologies are categorized into 6 groups which include material, additives, manufacture, cultivation, breeding and seed. The technology competitiveness of countries were analyzed with quantitative factors such as cites per patent, patent impact index, patent family size and technology strength. In comparison with other countries in the patent index, South Korea shows an increasing trend in patent numbers and total leverage ability, although the individual technology is lower than Japan and USA. Our study provides information on technical trend to support the performance of new projects on balloon flower.

  • PDF

A Case of Idiopathic Isolated Hypoglossal Nerve Palsy (특발성 단독설하신경마비 1례)

  • Kim, Doo-Hyun;Lee, Se-Jin
    • Journal of Yeungnam Medical Science
    • /
    • v.27 no.1
    • /
    • pp.74-77
    • /
    • 2010
  • Isolated hypoglossal nerve palsy is a rare clinical condition and it causes deviation of the tongue and dysarthria. A 50-year-old female presented with tongue deviation to the left and mild dysarthria. She had no remarkable past medical history except several recent upper respiratory infections. On examination, the other cranial nerves were intact and she had no focal neurological signs. The findings of MRI and MR angiography were normal. Cerebrospinal fluid analysis revealed only mild elevation of protein. We diagnosed her as suffering with idiopathic isolated hypoglossal nerver palsy and we administered steroid therapy. The dysarthria was improved, but the tongue deviation still remained at 50 days after onset. We report here on a rare case of idiopathic isolated hypoglossal nerve palsy.

  • PDF

COVID-19: An overview of current scenario

  • Malik, Jonaid Ahmad;Maqbool, Mudasir
    • CELLMED
    • /
    • v.10 no.3
    • /
    • pp.21.1-21.8
    • /
    • 2020
  • Over a span of few decades, the world has seen the emergence of new viruses that have posed serious problems to global health .COVID-19 is a major pathogenic threat to the modern world that primarily shoots the respiratory system of human beings. Wuhan which is the capital city of Hubei, China was the first place in the world where first cases of COVID-19 emerged and the scores of cases significantly increased at an immense rate leading to city isolation and establishment of new specially designed hospitals. SARS-CoV had emerged from bats in china (2002) and MERS-CoV from camels transmitted via bats in Middle East (2012) where the previous versions of COVID-19 took place. Infections with SARS-CoV-2 are now widespread, like Nuclear Chain Reaction (NRC). In this review we will discuss the COVID-19 origin, transmission, incubation, diagnosis and therapies available at the present scenario.